分散要素による臨床試験における患者中心性とデータ整合性の評価方法論: マスティックガムの試験試験
Jiyeon Park1, Ki Young Huh1, Jae-Yong Chung2
1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Clinical and translational science
|September 4, 2025
まとめ
新しい方法は分散型臨床試験における患者中心性とデータの完全性を評価します これらのツールは,試験活動を従来の場所から外に移す影響を評価し,将来の試験設計を改善するのに役立ちます.
科学分野:
- 臨床試験の方法論
- 患者 を 中心 に する 治療
- データの完全性
背景:
- 分散型臨床試験は 患者を中心に活動することを促進します
- 分散型試験における遠隔データ収集は,データの完全性に対するリスクをもたらします.
- これらの重要な側面を評価する現在の方法は限られています.
研究 の 目的:
- 分散試験における患者中心性を測定するための方法論を提案し,検証する.
- 分散型試験の要素におけるデータの整合性を評価するための分析的枠組みを導入する.
- パイロット研究でこれらの方法の実現可能性を探求する.
主な方法:
- 患者中心性は,従来のアプローチと自己評価された負担を比較することによって測定されます.
- データの完全性は,正確なパフォーマンス率,エラーの源,および結果によって評価されます.
- マスティックガムの臨床試験に用いられた方法論
主要な成果:
- 患者中心性はウェアラブル・ドラッグ・モニタリング (4.30) で最高で,リモート・コンセント (1.80) で最低です.
- ウェアラブルモニタリングのデータ完全性は最低 (88.6%),デバイスの問題と接続性によるエラーがあります.
- セルフキットによる便の収集はデータ完全性 (90. 0%) が低く,分析の遅延を引き起こした.
結論:
- 提案された方法論は,分散試験の影響を評価するための基盤を提供します.
- これらのツールは,患者中心性とデータ整合性に関連する課題を予測し,管理するのに役立ちます.
- これらの方法をさらに応用することで 分散型臨床試験の設計を最適化できます
さらに関連する動画
関連する概念動画
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Study Designs in Epidemiology
410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410
Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382


